Studying resistant bacteria in urine infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You had a urinary tract infection (UTI) treated by a primary care doctor between June 1, 2024 and December 31, 2024
- You agree to let the researchers use your medical data for this study
- Your primary care doctor agrees to participate in the study as well
- You are not under legal guardianship or protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at complicated urinary tract infections (UTIs), which are infections in the urinary system that happen when there is an underlying issue like a urinary catheter, blockage, or other urinary tract problem. The trial aims to gather information to better understand and treat these infections.
This study collects and studies bacteria (E. coli) found in urine from people with urinary tract infections, including those with repeat infections. It may help improve how doctors understand these infections and choose better future treatments.
This study looks at whether next-generation DNA testing from your urine can help doctors make better decisions about your treatment. You may be asked to return for follow-up visits so researchers can compare outcomes over time.
This study helps doctors choose the best antibiotic for urinary tract infections (UTIs) by looking at urine culture results. You'll be treated as an outpatient (at home) and monitored to see if your antibiotic is working well.
This study looks at the bacteria living in the vagina, urine tract, and stool to learn why some women get repeated urinary tract infections (UTIs). The results may help doctors better prevent or treat UTIs in the future.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.